TL;DR
A new VA policy for younger veterans requires signed consent and documented discussion of antidepressant risks and benefits before a prescription. Separate studies reported that an investigational smartphone app reduced negative symptoms in schizophrenia and that reducing ultraprocessed foods was associated with lower depression and anxiety scores in a small pilot trial. The findings have limits, and details of the VA policy’s age range and implementation are not provided in the source report.
The U.S. Department of Veterans Affairs will require younger veterans to sign consent forms and have documented discussions about antidepressant risks and benefits before receiving a prescription, according to a September 30 report citing The New York Times. The same psychiatry roundup highlighted two separate research findings: an investigational app reduced negative symptoms in a schizophrenia trial, while a small diet study found lower depression and anxiety scores after participants reduced ultraprocessed foods.
The VA policy adds a formal consent step to antidepressant prescribing for younger veterans. The report says clinicians must document discussions of risks and benefits and obtain signed forms before prescribing. It does not specify the age cutoff, when the policy takes effect, which antidepressants are covered, or what exceptions may apply.
In a randomized trial published in JAMA Network Open, an investigational smartphone app reduced the severity of negative symptoms in people with schizophrenia, according to the roundup. Negative symptoms can include reduced motivation or social engagement. The report does not provide the number of participants, the size or duration of the effect, or whether the app was compared with a particular standard of care.
A small pilot crossover trial published in JAMA Psychiatry found that patients with major depressive disorder had lower depression and anxiety scores when they reduced ultraprocessed foods, the roundup said. A crossover design lets participants experience more than one study condition, but the brief report gives no sample size, study duration, or score changes. It describes an association during the intervention, not proof that a diet change treats depression.
New Consent Steps for Veterans
The VA policy could change how antidepressant treatment is discussed and documented for younger veterans. A required conversation and signed form may make risks and benefits more explicit before treatment begins. The source report does not establish whether the policy will affect prescribing rates or patient outcomes.
The two studies raise different possibilities for care: a digital tool may help address schizophrenia symptoms, while food choices may be relevant to depression research. Both reports are preliminary as presented. The app finding comes from a randomized trial, but further details are needed to judge its scale and practical use; the diet result is from a small pilot study and cannot establish a general treatment effect.
Top picks for "antidepressant aids schizophrenia"
As an affiliate, we earn on qualifying purchases.
Three Developments in Psychiatry
The policy and research findings appeared in a short psychiatry news roundup published by Medpage Today on September 30, 2026. The roundup drew on reporting by The New York Times for the VA policy and research published in JAMA Network Open and JAMA Psychiatry for the app and diet findings.
The roundup also placed the items among other mental health developments, including national suicide figures and reports of rising pediatric mental health emergency visits at one Colorado hospital. Those separate items provide broader context for mental health coverage but do not establish a connection to the VA policy or the two studies.
Policy and Trial Details Pending
The source report does not identify which veterans qualify as “younger,” when the VA rule starts, or how consent will be handled in urgent situations. It also does not provide the policy text or a direct statement from VA officials.
For the studies, key details remain absent from the roundup: participant counts, effect sizes, follow-up periods, and app design or availability. The diet trial is described as small, with no reported comparison figures. It is not clear whether either intervention’s effects persisted after the study period or how well the results apply beyond the participants studied.
Implementation and Follow-Up Evidence
Further reporting on the VA policy may clarify its age range, start date, and clinical exceptions. Veterans and clinicians will need those details to understand how the consent process fits into prescribing visits.
For the app and diet findings, the next useful information will come from the full study reports and additional research that measures effect size, duration, and outcomes in larger or more varied groups. The roundup does not announce a timeline for follow-up studies or broader app access.
Key Questions
What does the new VA antidepressant policy require?
According to the report, younger veterans must sign consent forms and have documented discussions about antidepressant risks and benefits before receiving a prescription.
Who counts as a younger veteran under the policy?
The source report does not give an age cutoff. It also does not say when the policy takes effect.
What did the schizophrenia app trial find?
A randomized trial reported that an investigational smartphone app reduced the severity of negative symptoms. The roundup does not provide the effect size, participant count, or details about the app.
Does the diet study show that avoiding ultraprocessed food treats depression?
No. The small pilot crossover trial found lower depression and anxiety scores when participants with major depressive disorder reduced ultraprocessed foods. The brief report does not establish that the change caused the improvement or that it works as a treatment for others.
Source: rss
